Philadelphia Pharma at the 19th Pan-Arab Neurology Congress (PAUNS) & 31st National Congress of the Tunisian Society of Neurology (STN)
On the occasion of the PAUNS–STN dual congress, celebrating the 50th anniversary of PAUNS, Philadelphia Pharma had the honor of participating in this major scientific event, held under the high patronage of the World Federation of Neurology (WFN). The congress brought together experts from across the Arab world to discuss the latest advances in neurology, including stroke management, Parkinson’s disease, multiple sclerosis (MS), epilepsy, dementia, and the application of artificial intelligence in medicine.
Key Activities and Highlights:
Official participation of Philadelphia Pharma as a committed scientific partner.
Enriching exchanges with opinion leaders, neurologists, researchers, and healthcare professionals.
Promotion of targeted therapeutic solutions in neuroscience.
Interactive booth facilitating meetings between experts and industry representatives.
Support for innovation, research, and medical collaboration across the MENA region.
Celebration of 50 years of PAUNS, a historic milestone for Arab neurology.
Philadelphia Pharma reaffirms its active role in supporting the Tunisian and Arab medical community, committed to a future where neurology is synonymous with progress, accessibility, and excellence.